Publication:
SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

Simple item page
dc.contributor.authorSepulveda-Sanchez, J M
dc.contributor.authorMuñoz-Langa, J
dc.contributor.authorArraez, M A
dc.contributor.authorFuster, J
dc.contributor.authorHernandez Lain, A
dc.contributor.authorReynes, G
dc.contributor.authorRodriguez-Gonzalez, V
dc.contributor.authorVicente, E
dc.contributor.authorVidal-Denis, M
dc.contributor.authorGallego, O
dc.date.accessioned2023-01-25T10:01:20Z
dc.date.available2023-01-25T10:01:20Z
dc.date.issued2017-11-09
dc.description.abstractDiffuse infiltrating low-grade gliomas include oligodendrogliomas and astrocytomas, and account for about 5% of all primary brain tumors. Treatment strategies for these low-grade gliomas in adults have recently changed. The 2016 World Health Organization (WHO) classification has updated the definition of these tumors to include their molecular characterization, including the presence of isocitrate dehydrogenase (IDH) mutation and 1p/19p codeletion. In this new classification, the histologic subtype of grade II-mixed oligoastrocytoma has also been eliminated. The precise optimal management of patients with low-grade glioma after resection remains to be determined. The risk-benefit ratio of adjuvant treatment must be weighed for each individual.
dc.description.versionSi
dc.identifier.citationSepúlveda-Sánchez JM, Muñoz Langa J, Arráez MÁ, Fuster J, Hernández Laín A, Reynés G, et al. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017). Clin Transl Oncol. 2018 Jan;20(1):3-15
dc.identifier.doi10.1007/s12094-017-1790-3
dc.identifier.essn1699-3055
dc.identifier.pmcPMC5785601
dc.identifier.pmid29124520
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785601/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-017-1790-3.pdf
dc.identifier.urihttp://hdl.handle.net/10668/11787
dc.issue.number1
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.page.number13
dc.provenanceRealizada la curación de contenido 19/03/2025
dc.publisherSpringer
dc.pubmedtypeJournal Article
dc.pubmedtypePractice Guideline
dc.relation.publisherversionhttps://dx.doi.org/10.1007/s12094-017-1790-3
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAstrocytoma
dc.subjectGuideline
dc.subjectLow-grade glioma
dc.subjectNeurooncology
dc.subjectOligodendroglioma
dc.subject.decsClasificación
dc.subject.decsEstrategias de Salud
dc.subject.decsIsocitrato Deshidrogenasa
dc.subject.decsMutación
dc.subject.decsAstrocitoma
dc.subject.meshBrain Neoplasms
dc.subject.meshGlioma
dc.subject.meshHumans
dc.titleSEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number20
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
PMC5785601.pdf
Size:
2.1 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
Sepulveda-Sanchez_SEOMClinical_Correccion.pdf
Size:
604.89 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Regional Universitario de Málaga

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía